Jane Street’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-110,924
Closed -$1.45M 13155
2025
Q4
$1.89M Sell
110,924
-508,717
-82% -$5.17M ﹤0.01% 4926
2025
Q3
$4.54M Buy
+619,641
New +$5.01M ﹤0.01% 3565
2024
Q4
Sell
-142,014
Closed -$1.9M 10744
2024
Q3
$1.16M Buy
142,014
+35,472
+33% +$212K ﹤0.01% 5587
2024
Q2
$532K Buy
106,542
+69,207
+185% +$395K ﹤0.01% 6924
2024
Q1
$230K Sell
37,335
-42,103
-53% -$211K ﹤0.01% 7974
2023
Q4
$401K Buy
+79,438
New +$425K ﹤0.01% 7153
2023
Q2
Sell
-372,481
Closed -$1.61M 9682
2023
Q1
$1.61M Buy
372,481
+268,454
+258% +$1.23M ﹤0.01% 4189
2022
Q4
$728K Buy
+104,027
New +$479K ﹤0.01% 5517
2021
Q4
Sell
-38,069
Closed -$158K 10898
2021
Q3
$187K Buy
38,069
+26,551
+231% +$161K ﹤0.01% 8898
2021
Q2
$76K Sell
11,518
-87,558
-88% -$572K ﹤0.01% 9379
2021
Q1
$555K Buy
99,076
+88,188
+810% +$847K ﹤0.01% 6606
2020
Q4
$86K Sell
10,888
-96,541
-90% -$810K ﹤0.01% 7241
2020
Q3
$913K Buy
+107,429
New +$1.18M ﹤0.01% 4237
2020
Q1
Sell
-33,873
Closed -$271K 6079
2019
Q4
$271K Buy
+33,873
New +$830K ﹤0.01% 4401
2018
Q4
Sell
-4,193
Closed -$210K 5822
2018
Q3
$210K Buy
+4,193
New +$189K ﹤0.01% 4633

Other funds holding WVE

Jane Street's WVE Position: Q1 2026 in Review

Jane Street sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 110,924 shares — an estimated $1.45M sold.

Jane Street first reported a position in WVE in Q3 2018 and held it in 15 quarters. The position peaked at $4.54M in Q3 2025. 232 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Jane Street reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 110,924 Wave Life Sciences shares in Q1 2026, an estimated $1.45M.
  • Jane Street first reported a position in Wave Life Sciences in Q3 2018 and held it in 15 quarters.
  • Jane Street's Wave Life Sciences position peaked at $4.54M in Q3 2025.
  • 232 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.